EGFR-IN-89

Modify Date: 2024-01-08 12:34:23

EGFR-IN-89 structure	Common Name	EGFR-IN-89
	CAS Number	2413029-40-8	Molecular Weight	538.64
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₃₁FN₈O₂S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of EGFR-IN-89

EGFR-IN-89 (compound 13k) is a potent, fourth-generation EGFR mutation inhibitor with an IC50 of 10.1 nM against Del19/T790M/C797S mutations. EGFR-IN-89 shows higher selectivity over wild type[1].

Name	EGFR-IN-89

Description	EGFR-IN-89 (compound 13k) is a potent, fourth-generation EGFR mutation inhibitor with an IC50 of 10.1 nM against Del19/T790M/C797S mutations. EGFR-IN-89 shows higher selectivity over wild type[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> EGFR Signaling Pathways >> Protein Tyrosine Kinase/RTK >> EGFR
Target	EGFR19del/TM/CS:10.1 nM (IC50)
References	[1]. Jiyoung Jeon, et al. Design and synthesis of 4th generation EGFR inhibitors against human triple (Del19/T790M/C797S) mutation. Eur J Med Chem. 2023 Sep 27:261:115840.

Molecular Formula	C₂₆H₃₁FN₈O₂S
Molecular Weight	538.64

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

EGFR-IN-89

Use of EGFR-IN-89

Names

EGFR-IN-89 Biological Activity

Chemical & Physical Properties